TSCA Reform Legislation Could Smooth Path For New Biotechnologies

Pending legislation in Congress to reform the 40-year-old Toxic Substances Control Act (TSCA) could make it easier for EPA to assess the potential risks of new technologies, such as synthetic biology, and review requests to undertake field research or commercialize new products, an industry attorney says. While the legislation does not “expressly address any of the issues” with biotechnology, nanotechnology or new technologies specifically, “any legislative recast of TSCA will help with new technologies,” Lynn Bergeson, of the law firm...